I’m watching SL1 closely. Ready to pounce on confirmation all is well and targets are being meet. I agree SL1 is cheap the buts keep me from pulling the trigger on a lot more.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025